Expression of concern validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
被引:7
作者:
Collingridge, David
论文数: 0引用数: 0
h-index: 0
机构:
Lancet Oncol, London NW1 7BY, EnglandLancet Oncol, London NW1 7BY, England